KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
AcquisitionsCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)DivestmentsDividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresLong-Term Debt RepaymentsNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesShare-based CompensationShares IssuedShort-Term Debt issuances
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Universal Health Services (UHS) Cash from Investing Activities (2016 - 2025)

Universal Health Services (UHS) has disclosed Cash from Investing Activities for 17 consecutive years, with -$224.0 million as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Cash from Investing Activities fell 7.68% year-over-year to -$224.0 million, compared with a TTM value of -$1.1 billion through Dec 2025, down 17.51%, and an annual FY2025 reading of -$1.1 billion, down 17.51% over the prior year.
  • Cash from Investing Activities was -$224.0 million for Q4 2025 at Universal Health Services, up from -$269.4 million in the prior quarter.
  • Across five years, Cash from Investing Activities topped out at -$73.3 million in Q3 2022 and bottomed at -$305.9 million in Q2 2025.
  • Average Cash from Investing Activities over 5 years is -$215.3 million, with a median of -$222.7 million recorded in 2021.
  • The sharpest move saw Cash from Investing Activities surged 58.34% in 2022, then tumbled 140.6% in 2023.
  • Year by year, Cash from Investing Activities stood at -$254.8 million in 2021, then increased by 2.5% to -$248.4 million in 2022, then rose by 3.84% to -$238.8 million in 2023, then rose by 12.92% to -$208.0 million in 2024, then decreased by 7.68% to -$224.0 million in 2025.
  • Business Quant data shows Cash from Investing Activities for UHS at -$224.0 million in Q4 2025, -$269.4 million in Q3 2025, and -$305.9 million in Q2 2025.